DROPLET DIGITAL PCR IS A RELIABLE TOOL FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKAEMIA

被引：0
|
作者：
Brunetti, C. [1 ]
Anelli, L. [1 ]
Zagaria, A. [1 ]
Minervini, A. [1 ]
Casieri, P. [1 ]
Minervini, C. F. [1 ]
Orsini, P. [1 ]
Cumbo, C. [1 ]
Impera, L. [1 ]
Coccaro, N. [1 ]
Tota, G. [1 ]
Carluccio, P. [1 ]
Specchia, G. [1 ]
Albano, F. [1 ]
机构：
[1] Univ Bari, Hematol Sect, DETO, Bari, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P053
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [31] Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma
    Shirai, Ryota
    Osumi, Tomoo
    Keino, Dai
    Nakabayashi, Kazuhiko
    Uchiyama, Toru
    Sekiguchi, Masahiro
    Hiwatari, Mitsuteru
    Yoshida, Masanori
    Yoshida, Kaoru
    Yamada, Yuji
    Tomizawa, Daisuke
    Takae, Seido
    Kiyokawa, Nobutaka
    Matsumoto, Kimikazu
    Yoshioka, Takako
    Hata, Kenichiro
    Hori, Toshinori
    Suzuki, Nao
    Kato, Motohiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 910 - 918
  • [32] MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY DIGITAL-DROPLET-PCR (DDPCR) IN LYMPHOID MALIGNANCIES
    Della Starza, I.
    Del Giudice, I.
    Menale, L.
    Cappelli, L. V.
    Cavalli, M.
    De Novi, L. A.
    Apicella, V.
    Soscia, R.
    Cafforio, L.
    Mariglia, P.
    Chiaretti, S.
    Vitale, A.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2018, 103 : S40 - S40
  • [33] Quantitation of Minimal Residual Disease by Droplet Digital PCR in High-Risk Neuroblastoma Patients
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Thwin, Khin
    Uemura, Suguru
    Yamamoto, Nobuyuki
    Tamura, Akihiro
    Nino, Nanako
    Kozaki, Aiko
    Saito, Atsuro
    Kishimoto, Kenji
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Takafuji, Satoru
    Mori, Takeshi
    Iijima, Kazumoto
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S38 - S39
  • [34] Minimal residual disease monitoring in children with acute lymphoblastic leukaemia-PINDA-Chile
    Marinov, N.
    Cabrera, M. E.
    Campbell, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 87 - 87
  • [35] Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies
    Ommen, Hans Beier
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (01) : 3 - 16
  • [36] Minimal residual disease evaluation in acute myeloid leukaemia
    Yin, JAL
    Grimwade, D
    LANCET, 2002, 360 (9327): : 160 - 162
  • [37] Minimal residual disease in children with acute lymphoblastic leukaemia
    Catovsky, D
    Farahat, N
    Matutes, E
    Powles, RL
    Pinkerton, CR
    LANCET, 1998, 351 (9111): : 1287 - 1287
  • [38] An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia
    Nunes, Vittorio
    Cazzaniga, Gianni
    Biondi, A.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (11) : 953 - 963
  • [39] Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?
    Grimwade, David
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2011, 35 (01) : 3 - 7
  • [40] Molecular monitoring of residual disease in acute promyelocytic patients
    Haskovec, C
    Polák, J
    Pechová, R
    Lemez, P
    Zemanová, Z
    Michalová, K
    Krahulcová, E
    Penka, M
    Zák, P
    Schwarz, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 100 - 100
12345